Cargando…

Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging

Given that the increase in the aging population has grown into one of the largest public health issues, inflammation and oxidative stress, which are closely associated with the aging process, became a focus of recent research. Sodium-glucose co-transporter 2 (SGLT2) inhibitors, a group of drugs init...

Descripción completa

Detalles Bibliográficos
Autores principales: Schönberger, Ema, Mihaljević, Vjera, Steiner, Kristina, Šarić, Sandra, Kurevija, Tomislav, Majnarić, Ljiljana Trtica, Bilić Ćurčić, Ines, Canecki-Varžić, Silvija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487537/
https://www.ncbi.nlm.nih.gov/pubmed/37681811
http://dx.doi.org/10.3390/ijerph20176671
_version_ 1785103267118710784
author Schönberger, Ema
Mihaljević, Vjera
Steiner, Kristina
Šarić, Sandra
Kurevija, Tomislav
Majnarić, Ljiljana Trtica
Bilić Ćurčić, Ines
Canecki-Varžić, Silvija
author_facet Schönberger, Ema
Mihaljević, Vjera
Steiner, Kristina
Šarić, Sandra
Kurevija, Tomislav
Majnarić, Ljiljana Trtica
Bilić Ćurčić, Ines
Canecki-Varžić, Silvija
author_sort Schönberger, Ema
collection PubMed
description Given that the increase in the aging population has grown into one of the largest public health issues, inflammation and oxidative stress, which are closely associated with the aging process, became a focus of recent research. Sodium-glucose co-transporter 2 (SGLT2) inhibitors, a group of drugs initially developed as oral antidiabetics, have shown many beneficial effects over time, including improvement in renal function and cardioprotective effects. It has been shown that SGLT2 inhibitors, as a drug class, have an immunomodulatory and antioxidative effect, affecting endothelial function as well as metabolic parameters. Therefore, it is not surprising that various studies have investigated the potential mechanisms of action of SGLT2 inhibitors in age-related diseases. The proposed mechanisms by which SGLT2 inhibitors can achieve their anti-inflammatory effects include influence on AMPK/SIRT1/PGC-1α signaling, various cytokines, and the NLRP3 inflammasome. The antioxidative effect is related to their action on mitochondria and their influence on the signaling pathways of transforming growth factor β and nuclear erythroid 2-related factor 2/antioxidant response element. Also, SGLT2 inhibitors achieve their anti-inflammatory and antioxidative effects by affecting metabolic parameters, such as uric acid reduction, stimulation of ketogenesis, reduction of body weight, lipolysis, and epicardial fat tissue. Finally, SGLT2 inhibitors display anti-atherosclerotic effects that modulate inflammatory reactions, potentially resulting in improvement in endothelial function. This narrative review offers a complete and comprehensive overview of the possible pathophysiologic mechanisms of the SGLT2 inhibitors involved in the aging process and development of age-related disease. However, in order to use SGLT2 inhibitor drugs as an anti-aging therapy, further basic and clinical research is needed to elucidate the potential effects and complex mechanisms they have on inflammation processes.
format Online
Article
Text
id pubmed-10487537
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104875372023-09-09 Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging Schönberger, Ema Mihaljević, Vjera Steiner, Kristina Šarić, Sandra Kurevija, Tomislav Majnarić, Ljiljana Trtica Bilić Ćurčić, Ines Canecki-Varžić, Silvija Int J Environ Res Public Health Review Given that the increase in the aging population has grown into one of the largest public health issues, inflammation and oxidative stress, which are closely associated with the aging process, became a focus of recent research. Sodium-glucose co-transporter 2 (SGLT2) inhibitors, a group of drugs initially developed as oral antidiabetics, have shown many beneficial effects over time, including improvement in renal function and cardioprotective effects. It has been shown that SGLT2 inhibitors, as a drug class, have an immunomodulatory and antioxidative effect, affecting endothelial function as well as metabolic parameters. Therefore, it is not surprising that various studies have investigated the potential mechanisms of action of SGLT2 inhibitors in age-related diseases. The proposed mechanisms by which SGLT2 inhibitors can achieve their anti-inflammatory effects include influence on AMPK/SIRT1/PGC-1α signaling, various cytokines, and the NLRP3 inflammasome. The antioxidative effect is related to their action on mitochondria and their influence on the signaling pathways of transforming growth factor β and nuclear erythroid 2-related factor 2/antioxidant response element. Also, SGLT2 inhibitors achieve their anti-inflammatory and antioxidative effects by affecting metabolic parameters, such as uric acid reduction, stimulation of ketogenesis, reduction of body weight, lipolysis, and epicardial fat tissue. Finally, SGLT2 inhibitors display anti-atherosclerotic effects that modulate inflammatory reactions, potentially resulting in improvement in endothelial function. This narrative review offers a complete and comprehensive overview of the possible pathophysiologic mechanisms of the SGLT2 inhibitors involved in the aging process and development of age-related disease. However, in order to use SGLT2 inhibitor drugs as an anti-aging therapy, further basic and clinical research is needed to elucidate the potential effects and complex mechanisms they have on inflammation processes. MDPI 2023-08-29 /pmc/articles/PMC10487537/ /pubmed/37681811 http://dx.doi.org/10.3390/ijerph20176671 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Schönberger, Ema
Mihaljević, Vjera
Steiner, Kristina
Šarić, Sandra
Kurevija, Tomislav
Majnarić, Ljiljana Trtica
Bilić Ćurčić, Ines
Canecki-Varžić, Silvija
Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging
title Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging
title_full Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging
title_fullStr Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging
title_full_unstemmed Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging
title_short Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging
title_sort immunomodulatory effects of sglt2 inhibitors—targeting inflammation and oxidative stress in aging
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487537/
https://www.ncbi.nlm.nih.gov/pubmed/37681811
http://dx.doi.org/10.3390/ijerph20176671
work_keys_str_mv AT schonbergerema immunomodulatoryeffectsofsglt2inhibitorstargetinginflammationandoxidativestressinaging
AT mihaljevicvjera immunomodulatoryeffectsofsglt2inhibitorstargetinginflammationandoxidativestressinaging
AT steinerkristina immunomodulatoryeffectsofsglt2inhibitorstargetinginflammationandoxidativestressinaging
AT saricsandra immunomodulatoryeffectsofsglt2inhibitorstargetinginflammationandoxidativestressinaging
AT kurevijatomislav immunomodulatoryeffectsofsglt2inhibitorstargetinginflammationandoxidativestressinaging
AT majnaricljiljanatrtica immunomodulatoryeffectsofsglt2inhibitorstargetinginflammationandoxidativestressinaging
AT biliccurcicines immunomodulatoryeffectsofsglt2inhibitorstargetinginflammationandoxidativestressinaging
AT caneckivarzicsilvija immunomodulatoryeffectsofsglt2inhibitorstargetinginflammationandoxidativestressinaging